Fundraising FoxAvisa Pharma Inc.
Santa Fe, US · Founded 2010 · Delaware corporation · 1 known investors
Find your way into Avisa Pharma Inc.
Sign up to see every warm intro you have to Avisa Pharma Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avisa Pharma Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MC
Matthew CullerExecutive
DS
David S. JosephExecutive
Board
TR
Thomas R. MorseBoard director
BP
WA
William A. MillerBoard director
CJ
Chuck J. MorrisonBoard director
SS
Stuart SchoenmanBoard director
AB
Allan BedwickBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$10.5M disclosed across 7 rounds · 2014–2021
▶$693.3KraisedMay 2021 · 21 investors · Other Health CareRule 506(b)
▶$693.3KraisedMay 2021 · 21 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Thomas R. MorseDirector
- Matthew CullerExecutive Officer
- Brian P. BirkDirector
- William A. MillerDirector
- David S. JosephExecutive Officer, Director
- Chuck J. MorrisonDirector
- Offering amount
- $693.3K
- Amount sold
- $693.3K
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$495KraisedDec 2020 · 30 investors · Other Health CareRule 506(b)
▶$495KraisedDec 2020 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- J. Chuck MorrisonDirector
- Matt CullerDirector
- David S. JosephExecutive Officer, Director
- William A. MillerDirector
- Brian P. BirkDirector
- Thomas R. MorseDirector
- Offering amount
- $495K
- Amount sold
- $495K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$200KraisedDec 2020 · 6 investors · Other Health CareRule 506(b)
▶$200KraisedDec 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David S. JosephExecutive Officer, Director
- Thomas R. MorseDirector
- William A. MillerDirector
- Brian P. BirkDirector
- Matt CullerExecutive Officer
- J. Chuck MorrisonDirector
- Offering amount
- $200K
- Amount sold
- $200K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$734.2KraisedSep 2020 · 23 investors · Other Health CareRule 506(b)
▶$734.2KraisedSep 2020 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William A. MillerDirector
- David S. JosephExecutive Officer, Director
- Brian P. BirkDirector
- Thomas R. MorseDirector
- J. Chuck MorrisonDirector
- Matt CullerExecutive Officer
- Offering amount
- $734.2K
- Amount sold
- $734.2K
- Sales commissions
- $58.7K
- Proceeds to insiders
- $51.1K
- Placement agents
- Haywood Securities (USA) Inc.
- First sale
- Sep 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedMar 2020 · 12 investors · Other Health CareRule 506(b)
▶$1.1MraisedMar 2020 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Stuart SchoenmannDirector
- Thomas R. MorseDirector
- William A. MillerDirector
- Allan BedwickDirector
- David S. JosephExecutive Officer, Director
- Brian P. BirkDirector
- J. Chuck MorrisonDirector
- Matt CullerExecutive Officer
- Offering amount
- $1.4M
- Amount sold
- $1.1M
- Proceeds to insiders
- $250K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.6MraisedJun 2018 · 51 investors · Other Health CareRule 506(b)
▶$3.6MraisedJun 2018 · 51 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Allan BedwickDirector
- William A. MillerDirector
- Brian P. BirkDirector
- Stuart SchoenmannDirector
- Thomas R. MorseDirector
- David S. JosephExecutive Officer, Director
- Matt CullerExecutive Officer
- Offering amount
- $6M
- Amount sold
- $3.6M
- Proceeds to insiders
- $300K
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$3.7MraisedOct 2014 · 23 investors · Other Health CareRule 506(b)
▶$3.7MraisedOct 2014 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David S. JosephExecutive Officer, Director
- Stuart SchoenmanDirector
- Allan BedwickDirector
- William A. MillerDirector
- Tom MorseDirector
- Offering amount
- $4M
- Amount sold
- $3.7M
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Avisa Pharma Inc.'s investors?
- Avisa Pharma Inc.'s investors include Sun Mountain Capital.
- How much funding has Avisa Pharma Inc. raised?
- Avisa Pharma Inc. has disclosed $10.5M raised across 7 rounds.
- Where is Avisa Pharma Inc. headquartered?
- Avisa Pharma Inc. is headquartered in Santa Fe, US.